TNF and arthritic joint disease: Previous studies have reported that rheumatoid cachexia can persist in RA patients receiving biotherapy, even after arthritis symptoms improve, and treatment with anti-TNF preparations and other biologic therapies may result in elevated lipid subcomponents.